Status:
COMPLETED
PENG Block for Arthroscopic Hip Surgery
Lead Sponsor:
University of Virginia
Conditions:
Postoperative Pain
Hip Arthroscopy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This randomized, double-blinded, placebo-controlled trial seeks to evaluate the analgesic efficacy of the pericapsular nerve group block in the setting of outpatient hip arthroscopy.
Detailed Description
The pericapsular nerve group, or PENG block, has been recently described and shows promise in providing analgesia to the hip joint. The analgesic value of this block in the setting of hip arthroscopy ...
Eligibility Criteria
Inclusion
- Patients \> 18 years old undergoing unilateral hip arthroscopy at the outpatient surgery center.
Exclusion
- refusal to participate
- \< 18 yo
- Chronic opioid use
- localized infection
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 8 2022
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04508504
Start Date
December 1 2020
End Date
February 8 2022
Last Update
March 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UVA Outpatient Surgery Center
Charlottesville, Virginia, United States, 22903